// App-Quantinova.ai

: Tislelizumab combined with anlotinib and chemotherapy (XELOX) in the treatment of advanced gastric carcinoma: Preliminary results of a single-arm, open-label phase I/IIa trial (TALENT study).

Researchers

Presenter

  • Xiaofeng Chen

Principal Investigators

  • Deqiang Wang

  • Yuan Yuan

  • Jie Tang

  • Fen Guo

  • Yizhang Chen

  • Junli Ding

  • Tingting Hong

  • Binbin Lu

  • Wei Li

  • Rong Wang

  • Yitong Tian

  • Lanlan Pan

  • Jiaguang Zhang

  • Xinyi Zhang

  • Tongpeng Xu

  • Hao Xu

  • Yongqian Shu

Medical Centers

  • Department of Oncology, Liyang Branch of Jiangsu People's Hospital, Liyang, China

  • Department of Oncology, The First Affiliated Hospital of An Hui Medical University, Hefei, China

  • Affiliated Wuxi People's Hospital of Nanjing Medical University,

  • Huizhou Central Hospital, Huizhou, China

  • Medical Oncology, Suzhou Municipal Hospital, Suzhou, China

  • Department of Oncology, The First Affiliated Hospital of An Hui Medical University, Hefei, China

  • Affiliated Hospital of Jiangnan University, Wuxi, China

  • Department of Oncology, The First Affiliated Hospital of An Hui Medical University, Hefei, China

  • Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang, China

  • Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang, China

  • Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China

  • Department of Medical Oncology, Cancer Therapy Center, Affiliated Hospital of Jiangsu University, Zhenjiang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Tislelizumab

  • anlotinib

  • Capecitabine and oxaliplatin

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Multicenteric

  • Prospective

Phase

  • I/II

Study Id's

  • NCT04963088

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved